KEAP1 and Alzheimer disease: Numerous preclinical and clinical studies in AD patients indicate that various phytochemicals, including naringenin, curcumin, methysticin, resveratrol, berberine, trigonelline, astaxanthin and sulforaphane, may have beneficial effects, in part, by enhancing Nrf2/Keap1/ARE pathway activity.